Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Return on Equity (2016 - 2025)

Historic Return on Equity for Anika Therapeutics (ANIK) over the last 15 years, with Q3 2025 value amounting to 0.13%.

  • Anika Therapeutics' Return on Equity fell 700.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.26% for FY2024, which is 600.0% up from last year.
  • Latest data reveals that Anika Therapeutics reported Return on Equity of 0.13% as of Q3 2025, which was down 700.0% from 0.32% recorded in Q2 2025.
  • Anika Therapeutics' 5-year Return on Equity high stood at 0.05% for Q2 2024, and its period low was 0.32% during Q2 2025.
  • Moreover, its 5-year median value for Return on Equity was 0.03% (2022), whereas its average is 0.07%.
  • Per our database at Business Quant, Anika Therapeutics' Return on Equity soared by 1100bps in 2021 and then crashed by -3700bps in 2025.
  • Quarter analysis of 5 years shows Anika Therapeutics' Return on Equity stood at 0.02% in 2021, then tumbled by -98bps to 0.0% in 2022, then plummeted by -2667bps to 0.01% in 2023, then crashed by -1917bps to 0.28% in 2024, then surged by 55bps to 0.13% in 2025.
  • Its Return on Equity was 0.13% in Q3 2025, compared to 0.32% in Q2 2025 and 0.3% in Q1 2025.